Search Results 1491-1500 of 18460 for hypothyroidism

1. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Subjects with type I diabetes mellitus, hypothyroidism only requiring hormone replacement, skin disorders (such as vitiligo, psoriasis, or alopecia) not ...

2. Publications - Leslie C. Baxter, Ph.D. - Mayo Clinic

   Thyroid stimulating hormone and cognition during severe, transient hypothyroidism. Neuro Endocrinol Lett. 2011; 32 (3):279-85. View PubMed; Little AS, Liu S ...

3. A Study of RP2 with Nivolumab compared to Ipilimumab with Nivolumab with Metastatic Uveal Melanoma - Mayo Clinic

   Note: Patients with type 1 diabetes mellitus, hypothyroidism, or a similar chronic condition requiring only hormone replacement, or skin disorders (such as ...

4. Graves' disease - Doctors and departments - Mayo Clinic

   Learn about the symptoms, causes and treatment of this immune system condition that results in too much thyroid hormone.

5. Hemochromatosis - Doctors and departments - Mayo Clinic

   This liver condition usually runs in families. It causes your body to absorb too much iron from the foods you eat. Learn about symptoms, causes and ...

6. Study to Assess the Safety and Effectiveness of Oral BTD-001 in Adults with Idiopathic Hypersomnia - Mayo Clinic

   ... hypothyroidism (unless euthyroid at Screening Visit and treated with a stable dose of medication for at least 3 months prior to the Baseline Visit). The ...

7. A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors - Mayo Clinic

   ... hypothyroidism due to autoimmune thyroiditis only requiring hormone replacement are permitted to enroll. Participating Mayo Clinic locations. Study statuses ...

8. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   Patients with a history of autoimmune hypothyroidism on a stable dose of thyroid replacement hormone are eligible;; Patients with controlled type 1 diabetes ...

9. An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer - Mayo Clinic

   Subjects with vitiligo, type I diabetes mellitus, residual hypothyroidism due to autoimmune condition only requiring hormone replacement, psoriasis not ...

10. Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Relapsed/Refractory Large B-cell Lymphoma - Mayo Clinic

    Subjects with a history of autoimmune-related hypothyroidism on a stable dose of thyroid replacement hormone and subjects with controlled type 1 diabetes ...